The Impacts of Aspergillosis on Outcome, Burden and Risks for Mortality in Influenza Patients with Critical Illness

doi:10.3390/jof7110922

CNU IR > College of Smart Living > Dept. of Hospital and Health (including master's program) > Periodical Articles > Item 310902800/34337

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34337

Title:	The Impacts of Aspergillosis on Outcome, Burden and Risks for Mortality in Influenza Patients with Critical Illness
Authors:	Chao, Chien-Ming Lai, Chih-Cheng Ou, Hsuan-Fu Ho, Chung-Han Chan, Khee-Siang Yang, Chun-Chieh Chen, Chin-Ming Yu, Wen-Liang
Contributors:	Chi Mei Med Ctr, Dept Intens Care Med Min Hwei Coll Hlth Care Management, Dept Dent Lab Technol Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med Chi Mei Med Ctr, Dept Intens Care Med Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm Sci, Dept Hosp & Hlth Care Adm Chi Mei Med Ctr, Dept Intens Care Med Taipei Med Univ, Sch Med, Dept Med, Coll Med
Keywords:	aspergillosis influenza outcome intensive care unit mortality
Date:	2021
Issue Date:	2023-11-11 11:44:28 (UTC+8)
Publisher:	MDPI
Abstract:	Previous studies have revealed higher mortality rates in patients with severe influenza who are coinfected with invasive pulmonary aspergillosis (IPA) than in those without IPA coinfection; nonetheless, the clinical impact of IPA on economic burden and risk factors for mortality in critically ill influenza patients remains undefined. The study was retrospectively conducted in three institutes. From 2016 through 2018, all adult patients with severe influenza admitted to an intensive care unit (ICU) were identified. All patients were classified as group 1, patients with concomitant severe influenza and IPA; group 2, severe influenza patients without IPA; and group 3, severe influenza patients without testing for IPA. Overall, there were 201 patients enrolled, including group 1 (n = 40), group 2 (n = 50), and group 3 (n = 111). Group 1 patients had a significantly higher mortality rate (20/40, 50%) than that of group 2 (6/50, 12%) and group 3 (18/11, 16.2%), p < 0.001. The risk factors for IPA occurrence were solid cancer and prolonged corticosteroid use in ICU of > 5 days. Group 1 patients had significantly longer hospital stay and higher medical expenditure than the other two groups. The risk factors for mortality in group 1 patients included patients' Charlson comorbidity index, presenting APACHE II score, and complication of severe acute respiratory distress syndrome. Overall, IPA has a significant adverse impact on the outcome and economic burden of severe influenza patients, who should be promptly managed based on risk host factors for IPA occurrence and mortality risk factors for coinfection with both diseases.
Relation:	J FUNGI, v.7, n.11, pp.922
Appears in Collections:	[Dept. of Hospital and Health (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	213	View/Open
jof7110922.pdf		13273Kb	Adobe PDF	142	View/Open

Loading...